National Health Research Institutes

Taigen Biotechnology Company, Ltd.

Taigen Biotechnology

National Cheng-kung University

Chunghwa Telecom Co., Ltd.

Molecular Targeting Technologies. Inc.

Chien-Huang Wu

Kak-Shan Shia

Chi-Feng Yen

Ming-Chen Chou

Shu-Jen Chen

Chi-Hsin Richard King

Ying-Huey Huang

Chen-Tso Tseng

Yu-Sheng Chao

Gholam Hossein Hakimelahi

Cheng-Kung Hu

Chuan Shih

Yibin Xiang

Chiung-Tong Chen

Jang-Yang Chang

Yu-Huan Wang

Teng-Kuang Yeh

Meng-Ru Shen

Jen-Shin Song

Hua-Chien Chen

Jia-Liang Zhu

Lun-Kelvin Tsou

Yun Wang

Show-Ling Wu

Jhao-Siang Sun

Lun-Hsing Yeh

Shu-Fang Xiao

Pyrimidine compounds of formula (I) shown herein. Also disclosed are pharmaceutical compositions containing one of the pyrimidine compounds and methods of using the pyrimidine compounds to treat or prevent chemotherapy-induced peripheral neuropathy.

Pyrimidine compounds and use thereof

Heterocyclic compounds of Formula (I) shown herein. Also disclosed is a pharmaceutical composition containing one of the heterocyclic compounds. Further disclosed are methods of using one of the heterocyclic compounds for mobilizing hematopoietic stem cells and endothelial progenitor cells into the peripheral circulation, and for treating tissue injury, cancer, inflammatory disease, and autoimmune disease.

Heterocyclic compounds and use thereof

Dipicolylamine compounds of Formula (I) set forth herein. Also disclosed are pharmaceutical compositions containing metal ions and these compounds. Further disclosed is a method for treating a condition associated with cells containing inside-out phosphatidylserine, with these compounds.

Dipicolylamine derivatives and their pharmaceutical uses

Imidazol-4-one or imidazole-4-thione compounds of formula (I): wherein X, R, R, R, R, R, and Rare defined herein. Also disclosed is a method for treating a cannabinoid receptor-mediated disorder with these compounds.

Imidazol-4-one and imidazole-4-thione compounds

This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification. 

Pyrimidine compounds

The apparatus is applicable to a communications network, wherein, via an information processing platform of a network server end, the system is connected to a network surveillance device installed in a monitored environment, in which the information processing platform processes and saves event message about the environment acquired by the network surveillance device, and generates corresponding notification messages. Via a browsing authorization certification mechanism, the system allows a user having been identified as a certified user to connect to the information processing platform via a communication terminal device for monitoring message information. Using the system, a certified user is capable of the following: accessing or receiving surveillance message information via the information processing platform, receiving notification message from the information processing platform, accessing the information processing platform to manage and maintain user authorized certification information, and/or selectively switching on/off connection between the network surveillance device and the information processing platform.

Residential security surveillance and notification management system

This invention relates to methods for treating retinopathy and repairing tissue damage. The methods include administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification. 

Polyamine compounds

This invention relates to methods of preparing the compounds of formula (V): Each variable in this formula is defined in the specification.

Synthesis of polyamine compounds

Growing community of inventors

Taipei County, Taiwan

Chien-Huang Wu